Epidemiology and genetics of CTX-M extended-spectrum β-lactamases in Gram-negative bacteria

Wei-Hua Zhao1, Zhi-Qing Hu

  • 1Department of Microbiology and Immunology, Showa University School of Medicine, Tokyo, Japan. whzhao@med.showa-u.ac.jp

Insights

Extended-spectrum beta-lactamases (ESBLs) called CTX-M enzymes are a growing threat, found in many bacteria like E. coli. CTX-M-15 and CTX-M-14 are the most common types, spreading via plasmids.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Genetics

Background:

  • Extended-spectrum beta-lactamases (ESBLs) are enzymes that confer bacterial resistance to antibiotics.
  • CTX-M enzymes, a type of plasmid-mediated cefotaximase, represent a rapidly expanding family of ESBLs with considerable clinical significance.
  • These enzymes are prevalent across numerous bacterial species, notably in Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.

Purpose of the Study:

  • To provide an overview of the CTX-M enzyme family, including their diversity, prevalence, and mechanisms of spread.
  • To highlight the clinical impact and evolutionary origins of CTX-M enzymes.

Main Methods:

  • Phylogenetic analysis to classify CTX-M variants.
  • Literature review to assess prevalence and dissemination mechanisms.

Main Results:

  • Over 109 CTX-M members have been identified, categorized into seven distinct phylogenetic clusters.
  • CTX-M-15 and CTX-M-14 are the most frequently identified variants.
  • Evidence suggests chromosome-encoded cefotaximases in Kluyvera spp. are the likely progenitors of CTX-Ms.
  • Mobile genetic elements like ISEcp1 and ISCR1, along with plasmids, are strongly implicated in the mobilization and dissemination of CTX-M genes.

Conclusions:

  • The CTX-M family is diverse and expanding, posing a significant challenge in combating bacterial infections.
  • Understanding the evolutionary origins and dissemination pathways of CTX-M enzymes is crucial for developing effective control strategies.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...